1-20 of 111
Natarajan Muthusamy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Microenvironment-Induced Interleukin-6 Regulates Proliferation and Survival in Patients with Mantle Cell Lymphoma (MCL) By Activating FGFR1 Signaling

Yuangfeng Wang, Satishkumar Singh, Audrey Odier, Alessandro La Ferlita, Wing Chan, Maxine Berger, Sriya Sreekanth, Narendranath Epperla, Natarajan Muthusamy, Robert Baiocchi, Lapo Alinari, Mamta Gupta, Lalit Sehgal
Journal: Blood
Blood (2024) 144 (Supplement 1): 4371.
https://doi.org/10.1182/blood-2024-209186
Published: 2024
Journal Articles

Transcriptomic Analysis in Mantle Cell Lymphoma Patients Identified MALAT1 Long-Non-Coding RNA to Regulate Cell Cycle Progression By Modulating EZH2/p57/Sox11 Axis

Satishkumar Singh, Alessandro La Ferlita, Neeraj Jain, Maxine Berger, Sriya Sreekanth, Rosario Distefano, Mamta Gupta, Natarajan Muthusamy, Robert Baiocchi, Lapo Alinari, Narendranath Epperla, Lalit Sehgal
Journal: Blood
Blood (2024) 144 (Supplement 1): 4350.
https://doi.org/10.1182/blood-2024-209941
Published: 2024
Journal Articles

To Catch a Killer: Delineating the Mechanistic Role of Siglec-6, a Novel Glycoprotein Target, for the Treatment of Chronic Lymphocytic Leukemia

Jessica Nunes, Ann Ventura, Kevan Zapolnik, Xiaokui Mo, Liwen Zhang, John C. Byrd, Christoph Rader, Natarajan Muthusamy
Journal: Blood
Blood (2022) 140 (Supplement 1): 9836ā€“9837.
https://doi.org/10.1182/blood-2022-171078
Published: 2022
Journal Articles

Age and Sex Differences in the EĪ¼-TCL1 Adoptive Transfer Mouse Model of CLL

Chia Sharpe, Elizabeth Perry, Erin Hertlein, Natarajan Muthusamy, John C. Byrd
Journal: Blood
Blood (2022) 140 (Supplement 1): 12367ā€“12368.
https://doi.org/10.1182/blood-2022-162900
Published: 2022
Journal Articles

Constitutive PRMT5 Expression Drives Spontaneous Lymphoblastic Lymphoma In Vivo

Lynda Villagomez, Porsha Smith, Fengting Yan, Victor Chen, Shelby Sloan, John T. Patton, Mackenzie Long, Fiona Brown, Elshafa H. Ahmed, Natarajan Muthusamy, Vincenzo Coppola, Anjali Mishra, Kris Vaddi, Peggy Scherle, Rosa Lapalombella, Lapo Alinari, Robert A. Baiocchi
Journal: Blood
Blood (2022) 140 (Supplement 1): 6381ā€“6382.
https://doi.org/10.1182/blood-2022-168160
Published: 2022
Journal Articles

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

Swagata Goswami, Rajeswaran Mani, Jessica Nunes, Chi-Ling Chiang, Kevan Zapolnik, Eileen Hu, Frank Frissora, Xiaokui Mo, Logan A. Walker, Pearlly Yan, Ralf Bundschuh, Larry Beaver, Raymond Devine, Yo-Ting Tsai, Ann Ventura, Zhiliang Xie, Min Chen, Rosa Lapalombella, Alison Walker, Alice Mims, Karilyn Larkin, Nicole Grieselhuber, Chad Bennett, Mitch Phelps, Erin Hertlein, Gregory Behbehani, Sumithira Vasu, John C. Byrd, Natarajan Muthusamy
Journal: Blood
Blood (2022) 139 (9): 1340ā€“1358.
https://doi.org/10.1182/blood.2020010344
Published: 2022
Includes: Supplemental data
Journal Articles

Ibrutinib Treatment in CLL Patients Improves T Cell Function and Blinatumomab Redirected Cytotoxicity

Meixiao Long, MD, Erich Williams, Clara Berard, Carolyn Cheney, BS, Eileen Hu, BS, Seema A. Bhat, MD, Kerry A. Rogers, MD, Jennifer Woyach, MD, Natarajan Muthusamy, DVM,PhD, John C. Byrd, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1049.
https://doi.org/10.1182/blood-2019-125417
Published: 2019
Journal Articles

LC-Facseq: A Novel Method for Detecting Rare Resistant Clones in Leukemia

Eileen Hu, BS, Hatice Gulcin Ozer, PhD, Arletta Lozanski, Tzyy-Jye Doong, Chi-Ling Chiang, PhD, Seema A. Bhat, MD, Kerry A. Rogers, MD, Jennifer Woyach, MD, James S. Blachly, MD, Gerard Lozanski, MD, Natarajan Muthusamy, DVM,PhD, John C. Byrd, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3377.
https://doi.org/10.1182/blood-2019-126070
Published: 2019
Journal Articles

IL-21-Expanded Natural Killer Cells As Autologous Cell Therapy for CLL

Max Yano, Jennie Rachel Lance, Xiaokui Mo, PhD MAS, Dean Anthony Lee, MD PhD, Natarajan Muthusamy, DVM,PhD, John C. Byrd, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4302.
https://doi.org/10.1182/blood-2019-127620
Published: 2019
Journal Articles

IL-21-Expanded NK Cells As Autologous Cell Therapy for CLL

Jennie Rachel Lance, Max Yano, Xiaokui Mo, PhD MAS, Dean Anthony Lee, MD PhD, Natarajan Muthusamy, DVM,PhD, John C. Byrd, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4303.
https://doi.org/10.1182/blood-2019-131034
Published: 2019
Journal Articles

Protein Phosphatase 2A Activation Dependent Down Regulation of PGC1-Alpha and FOXO1 Phosphorylation with OSU-2S in Human Lymphoma Cells

Sohaila Mohamed Khalil, Swagata Goswami, MSc, Xiaokui Mo, PhD MAS, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3977.
https://doi.org/10.1182/blood-2019-129224
Published: 2019
Journal Articles

ROR1 Targeted Immunoliposomal Delivery of OSU-2S Show Selective Cytotoxicity in t(1;19) Translocated B-ALL

Swagata Goswami, MSc, Chi-Ling Chiang, PhD, Kevan Zapolnik, BS, Zhiliang Xie, James L. Lee, PhD, Sivasubramanian Baskar, Christoph Rader, PhD, John C. Byrd, MD, Mitch A. Phelps, PhD, Bhavana Bhatnagar, DO, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3798.
https://doi.org/10.1182/blood-2019-128828
Published: 2019
Journal Articles

ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model

Chi-Ling Chiang, Swagata Goswami, Frank W. Frissora, Zhiliang Xie, Pearlly S. Yan, Ralf Bundschuh, Logan A. Walker, Xiaomeng Huang, Rajeswaran Mani, Xiaokui M. Mo, Sivasubramanian Baskar, Christoph Rader, Mitch A. Phelps, Guido Marcucci, John C. Byrd, L. James Lee, Natarajan Muthusamy
Journal: Blood
Blood (2019) 134 (5): 432ā€“444.
https://doi.org/10.1182/blood.2018882290
Published: 2019
Includes: Supplemental data
Journal Articles

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Eileen Hu, BS, Jessica Waibl-Polania, BS, Frank Frissora, MS, Larry State Beaver, Kevan Zapolnik, BS, Bethany L Mundy-Bosse, PhD, Anjali Mishra, PhD, Aharon G. Freud, MD PhD, Jianhua Yu, PhD, John C. Byrd, MD, Christopher C. Oakes, Michael Ostrowski, PhD, Natarajan Muthusamy, DVM, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2567.
https://doi.org/10.1182/blood-2018-99-115261
Published: 2018
Journal Articles

CD37 Expression in Acute Myeloid Leukemia Provides New Target for Directed Therapy

Karilyn Larkin, MD, Erin Guth, MS, Bonnie K. Harrington, DVM, Nicole Grieselhuber, MD PhD, Natarajan Muthusamy, DVM, PhD, John C. Byrd, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4056.
https://doi.org/10.1182/blood-2018-99-117262
Published: 2018
Journal Articles

Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia

Mary K. McKenna, Sunil K. Noothi, Sara S. Alhakeem, Karine Z. Oben, Joseph T. Greene, Rajeswaran Mani, Kathryn L. Perry, James P. Collard, Jacqueline R. Rivas, Gerhard C. Hildebrandt, Roger A. Fleischman, Eric B. Durbin, John C. Byrd, Chi Wang, Natarajan Muthusamy, Vivek M. Rangnekar, Subbarao Bondada
Journal: Blood
Blood (2018) 131 (26): 2943ā€“2954.
https://doi.org/10.1182/blood-2017-10-813931
Published: 2018
Includes: Supplemental data
Journal Articles

Par-4 Overexpression Impedes Leukemogenesis in the EĀµ-TCL1 Leukemia Model

Joseph Thomas Greene, BS, Rahul Ramaswamy, Mary K McKenna, BS, Rajeswaran Mani, DVM,PhD, Frank Frissora, MS, Ronni Wasmuth, BS, Minh Tran, BS, Xiaokui Mo, PhD MAS, Carlo M. Croce, MD, Vivek Rangnekar, PhD, John C. Byrd, MD, Subbarao Bondada, PhD, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1223.
https://doi.org/10.1182/blood.V130.Suppl_1.1223.1223
Published: 2017
Journal Articles

OSU-2S, a Novel PKC Activator, Mediates PKC Dependent Cell Death, Differentiation and Cell Cycle Arrest in Acute Myeloid Leukemia

Swagata Goswami, MS, Rajeswaran Mani, DVM,PhD, Xiaokui Mo, PhD MAS, Pearlly S. Yan, PhD, Michael B Broe, PhD, Ralf Bundschuh, PhD, Larry State Beaver, Kevan Zapolnik, BS, Zhiliang Xie, Donna Bucci, David M. Lucas, PhD, Allison R. Walker, MD MPH, Alice S. Mims, MD MSCR, Rebecca B. Klisovic, MD, Ching-Shih Chen, PhD, John C. Byrd, MD, Mitch A. Phelps, PhD, Sumithira Vasu, MDMBBS, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1247.
https://doi.org/10.1182/blood.V130.Suppl_1.1247.1247
Published: 2017
Journal Articles

A Phase 2 Trial of Early Intervention with Ibrutinib in Patients with Asymptomatic, High-Risk CLL

Farrukh T. Awan, MD MS, Shanmugapriya Thangavadivel, PhD, David Weiss, Lai Wei, PhD, Jennifer A. Woyach, MD, Kerry A. Rogers, MD, Jeffrey Jones, MD, Leslie Andritsos, MD, Natarajan Muthusamy, DVM,PhD, Barbara Andersen, PhD, John C. Byrd, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1748.
https://doi.org/10.1182/blood.V130.Suppl_1.1748.1748
Published: 2017
Journal Articles

Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Eileen Hu, BS, Priscilla Do, Rajeswaran Mani, DVM,PhD, Frank Frissora, MS, Haiyong Peng, PhD, Lorenz Waldmeier, PhD, Roger Beerli, PhD, Christoph Rader, PhD, Ulf Grawunder, PhD, John C. Byrd, MD, Natarajan Muthusamy, DVM,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3017.
https://doi.org/10.1182/blood.V130.Suppl_1.3017.3017
Published: 2017